Patents by Inventor Hans Richter

Hans Richter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070258161
    Abstract: A data recording device employs a bit patterned data recording medium that has an array of rows that are offset to one another. The rows are offset such that the bits are staggered in a direction that is normal to the direction in which the rows extend. The increased bit aspect ratio of the staggered bit pattern recording medium increases the linear recording density and enables a higher data recording rate.
    Type: Application
    Filed: May 8, 2006
    Publication date: November 8, 2007
    Inventors: Hans Richter, Alexander Dobin, Dieter Weller
  • Publication number: 20070244125
    Abstract: The present invention relates to compounds of formula I wherein G and R1 to R5 and R12 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: April 5, 2007
    Publication date: October 18, 2007
    Inventors: Matthias Nettekoven, Jean-Marc Plancher, Hans Richter, Olivier Roche, Sven Taylor
  • Patent number: 7253281
    Abstract: The present invention is directed to 1,2,3,4,10,10a,-hexahydropyrazino[1,2-a]indole derivatives as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R8 have the significance given in claim 1 be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: August 7, 2007
    Assignees: Hoffmann-La Roche Inc., Vernalis Research Limited
    Inventors: Jonathan Mark Bentley, Paul Hebeisen, Patrizio Mattei, Marc Muller, Hans Richter, Stephan Roever, Sven Taylor
  • Publication number: 20070135416
    Abstract: The present invention relates to compounds of formula I wherein A, G, r and R1 to R5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: November 29, 2006
    Publication date: June 14, 2007
    Inventors: Matthias Nettekoven, Jean-Marc Plancher, Hans Richter, Olivier Roche, Sven Taylor
  • Publication number: 20070123525
    Abstract: The present invention relates to compounds of formula I wherein R1 to R4 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: November 27, 2006
    Publication date: May 31, 2007
    Inventors: Matthias Nettekoven, Jean-Marc Plancher, Hans Richter, Olivier Roche, Sven Taylor
  • Publication number: 20070123515
    Abstract: The present invention relates to compounds of formula I wherein R1 to R4 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: November 27, 2006
    Publication date: May 31, 2007
    Inventors: Matthias Nettekoven, Jean-Marc Plancher, Hans Richter, Oliver Roche, Valerie Runtz-Schmitt, Sven Taylor
  • Publication number: 20070123526
    Abstract: The present invention relates to compounds of formula I wherein R1, R2 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: November 28, 2006
    Publication date: May 31, 2007
    Inventors: Matthias Nettekoven, Jean-Marc Plancher, Hans Richter, Olivier Roche, Rosa Rodriguez Sarmiento, Sven Taylor
  • Publication number: 20070106076
    Abstract: The present invention is directed to 1,2,3,4,10,10a,-hexahydropyrazino[1,2-a] indole derivatives as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R8 have the significance given in claim 1 be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea.
    Type: Application
    Filed: January 3, 2007
    Publication date: May 10, 2007
    Inventors: Jonathan Bentley, Paul Hebeisen, Patrizio Mattei, Marc Muller, Hans Richter, Stephan Roever, Sven Taylor
  • Patent number: 7208494
    Abstract: The present invention provides piperazine derivatives of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in the description. They can be used for the treatment of obesity.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: April 24, 2007
    Assignees: Hoffmann-La Roche Inc., Vernalis Research Limited
    Inventors: Toby Jonathan Blench, Paul Hebeisen, Hans Richter, Stephan Roever
  • Patent number: 7150613
    Abstract: The apparatus is a contamination free stamper holder for molding discs for information storage. The stamper, the disc part of the mold holding the pits and grooves to be formed on the molded plastic, is held within the mold by one or more magnets that are completely enclosed within non-magnetic material. The wall thickness of the enclosing material between the magnets and the stamper is limited so that there is no significant loss in magnetic attraction.
    Type: Grant
    Filed: April 21, 2005
    Date of Patent: December 19, 2006
    Assignee: Richter Precision Inc.
    Inventors: J. Hans Richter, George G. Ruth, Matthew E. Thompson
  • Publication number: 20060252759
    Abstract: The present invention refers to chemical compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in claim 1. These compounds can be used for the preparation of medicaments.
    Type: Application
    Filed: April 26, 2006
    Publication date: November 9, 2006
    Inventors: Paul Hebeisen, Nathaniel Monck, Hans Richter, Stephan Roever
  • Publication number: 20060228586
    Abstract: A ferromagnetically coupled magnetic recording medium having a first ferromagnetic layer, a second ferromagnetic layer, and a ferromagnetic coupling layer to ferromagnetically couple the first ferromagnetic layer to the second ferromagnetic layer is used as stable magnetic media with high MrT in high density recording hard drives. The first ferromagnetic layer is the stabilization layer and the second ferromagnetic layer is the main recording layer. The ferromagnetic coupling layer comprises a conductive material having a thickness which produces ferromagnetic coupling between said first ferromagnetic layer and said second ferromagnetic layer via the RKKY interaction.
    Type: Application
    Filed: April 6, 2005
    Publication date: October 12, 2006
    Inventors: Erol Girt, Mariana Muneanu, Hans Richter, Felix Trejo
  • Patent number: 7098337
    Abstract: The present invention relates to compounds of formula (I) as well as pharmaceutically acceptable salts, solvates and esters thereof. These compounds can be used to prepare pharmaceutical compositions for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.
    Type: Grant
    Filed: January 24, 2003
    Date of Patent: August 29, 2006
    Assignees: Hoffmann-La Roche Inc., Vernalis Research Limited
    Inventors: David Reginald Adams, Jonathan Mark Bentley, Toby Jonathan Blench, Paul Hebeisen, Nathaniel Julius Thomas Monck, Hans Richter, Stephan Roever, Jonathan Richard Anthony Roffey, Sven Taylor
  • Publication number: 20060178510
    Abstract: The present invention refers to chemical compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in claim 1. These compounds can be used for the preparation of medicaments.
    Type: Application
    Filed: January 13, 2006
    Publication date: August 10, 2006
    Inventors: Jonathan Bentley, Claire Dawson, Wolfgang Guba, Paul Hebeisen, Nathaniel Monck, Robert Pratt, Hans Richter, Stephan Roever, Vicki Ruston
  • Publication number: 20060139799
    Abstract: A granular perpendicular magnetic recording medium comprises a non-magnetic substrate and a granular perpendicular magnetic recording layer overlying the substrate, comprising a first granular perpendicular magnetic layer proximal the substrate and having a first saturation magnetization (Ms)1, and a second granular perpendicular magnetic layer distal the substrate and having a second, different saturation magnetization (Ms)2. Also disclosed is a method of fabricating the granular perpendicular magnetic recording medium.
    Type: Application
    Filed: December 28, 2004
    Publication date: June 29, 2006
    Inventors: Zhong Wu, Samuel Harkness, Hans Richter, Alexander Dobin
  • Publication number: 20060121318
    Abstract: A magnetic recording medium comprises a magnetically soft underlayer having a plurality of cavities in a surface thereof, and a magnetic recording material in the cavities, wherein a surface of the magnetic recording material in the cavities is substantially coplanar with the surface of the soft underlayer. A recording system that includes the recording medium is also included.
    Type: Application
    Filed: December 7, 2004
    Publication date: June 8, 2006
    Applicant: Seagate Technology LLC
    Inventors: Edward Gage, Gary Rauch, Rene Johannes van de Veerdonk, Hans Richter, Terry McDaniel, Mark Kryder
  • Patent number: 7034439
    Abstract: In a piezoelectric drive comprising clamping piezo packets which are adjacently arranged, under compressive pre-stress, between a reference part and an output part, the reference part is connected to the clamping piezo packets by means of a “semi-rigid” bridging plate, which adapts in a flexible manner to differences in stack height of the piezo packets, in a static state but remains essentially rigid in a dynamic state, that is, at the operating frequency of the drive.
    Type: Grant
    Filed: October 6, 2003
    Date of Patent: April 25, 2006
    Assignee: Gealan Formteile GmbH
    Inventor: Hans Richter
  • Publication number: 20060084679
    Abstract: The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof as well as to pharmaceutical compositions comprising these compounds and to methods for their preparation. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: October 14, 2005
    Publication date: April 20, 2006
    Inventors: Silvia McArthur, Cornelia Hertel, Matthias Nettekoven, Susanne Raab, Hans Richter, Olivier Roche, Rosa Rodriguez-Sarmiento, Franz Schuler
  • Publication number: 20050239789
    Abstract: The present invention is directed to 1,2,3,4,10,10a,-hexahydropyrazino[1,2-a]indole derivatives as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R8 have the significance given in claim 1 be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea.
    Type: Application
    Filed: June 28, 2005
    Publication date: October 27, 2005
    Inventors: Jonathan Bentley, Paul Hebeisen, Patrizio Mattei, Marc Muller, Hans Richter, Stephan Roever, Sven Taylor
  • Patent number: 6933387
    Abstract: The present invention is directed to 1,2,3,4,10,10a-hexahydropyrazino [1,2-a]indole derivatives of formula (I): as well as pharmaceutically acceptable salts, hydrates and esters thereof, wherein the substituents have the meanings provided in the specification. Compounds of the present invention may be used in the treatment or prevention of obesity or Type II diabetes.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: August 23, 2005
    Assignees: Hoffmann-La Roche Inc., Vernalis Research Limited
    Inventors: Jonathan Mark Bentley, Paul Hebeisen, Marc Muller, Hans Richter, Stephan Roever